Exchange: NYSEMkt·Updated 04:00 PM EDT
MAIA logo

MAIAMAIA Biotechnology Inc

$1.43
$0.01
(0.69%)
Today
Reported EarningsAug 5
Mkt Cap$87.55M
Vol260,884.00
News
all
press releases
News Placeholder
$207B Market Shift: The Race for Fast Track Approval in Oncology
$207B Market Shift: The Race for Fast Track Approval in Oncology $207B Market Shift: The Race for Fast Track Approval in Oncology PR Newswire VANCOUVER, BC, Feb. 5, 2026 Issued on behalf of...
PR Newswire
News Placeholder
MAIA’s New Agreement With Big Pharma Roche Turns Retail Investors Bullish As Stock Soars
The agreement aims to support future studies investigating the combination of MAIA’s Ateganosine and Roche’s checkpoint inhibitor, Atezolizumab, for safe and effective cancer treatments.
Stocktwits
<
...
1
>

Advertisement|Remove ads.